Target intelligence / Profile preview

Ribosomal protein L7 pseudogene 36 (RPL7P36)

Target: RPL7P36
Molecular classification: Other (pseudogene)

Overview

Ribosomal protein L7 pseudogene 36 (RPL7P36) is a processed pseudogene in the human genome derived from the ribosomal protein L7 (RPL7) gene[1][3][9]. Ribosomal protein L7 is a component of the large 60S ribosomal subunit, but RPL7P36 itself does not code for a functional protein[1][3]. Like most ribosomal protein pseudogenes, RPL7P36 lacks essential regulatory elements and is not known to be expressed or to participate in any biological pathways[5][9]. It is not implicated in disease, not used as a biomarker, nor described as a druggable therapeutic target[1][3][9].

Other names: RPL7_18_1089RPL7P36

Beyond the preview

Go deeper on Ribosomal protein L7 pseudogene 36 (RPL7P36).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7 pseudogene 36 (RPL7P36).

Explore the full profile